Effects of Green Coffee Bean Extract Supplementation on Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a major worldwide public health problem with no effective treatment options. Green coffee bean extract (GCBE) is a rich source of bioactive phytochemicals with a variety of biochemical and physiological effects. Objectives: The aim of this study was to investigate the effects of GCBE on the management of patients with NAFLD. Methods: 44 patients with NAFLD were enrolled in a parallel, double-blind, placebo-controlled clinical trial. The participants were administered either GCBE or placebo (1 gram/day) for 8 weeks. They also were advised to follow a standard energy-balanced diet and physical activity. Liver ultrasonography, anthropometric variables, and biochemical parameters were compared at pre- and post-intervention. Results: GCBE significantly improved the levels of aspartate aminotransferase (AST), triglyceride (TG), total cholesterol, free fatty acids (FFAs), fasting blood sugar (FBS), homeostasis model assessment insulin resistance (HOMA-IR) index, high-sensitivity C-reactive protein (hs-CRP), and total antioxidant capacity (TAC) compared to the placebo group. On the other hand, there were no significant differences between the two groups in body weight, HDL-cholesterol, LDL-cholesterol, LDL-C to HDL-C ratio, insulin, degree of steatosis, aspartate transaminase (AST), alkaline phosphatase (ALP), and tumor necrosis factor-alpha (TNF-α). Conclusions: GCBE supplementation may benefit patients with NAFLD. These beneficial effects may be due to the possible ability of GCBE to improve insulin sensitivity and its anti-inflammatory and antioxidant properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827 · cited 1×
“Several studies have shown that NAFLD patients have significantly higher serum levels of markers of oxidative stress and inflammation (43, 44).”
BackgroundUpdated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445 · cited 1×
“Participants’ eligibility included: age greater than 20; diagnosis of NAFLD determined by ultrasound (steatosis score equal or greater than 1) and serum levels of ALT higher than 19 U/l for women and 30 U/l for men (22), and body mass index (BMI = weight (kg)/height(2) (m)) greater than 24.”
BackgroundFatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Functional Properties of Coffee and Coffee By-Products
Esquivel, P., & Jiménez, V. M. (2012) · Food Research International · doi:10.1016/j.foodres.2011.05.028 · Cited by 847 · cited 6×
“However, coffee roasting process destroys significant amounts of the bioactive phytochemicals that are believed to be responsible for the biological actions, such as chlorogenic acid (11).”
BackgroundInfluentialMidlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428
Kempf, K., Herder, C., Erlund, I., Kolb, H., Martin, S., Carstensen, M., Koenig, W., Sundvall, J., Bidel, S., Kuha, S., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28548 · Cited by 364 · cited 1×
“In addition to differences in dosages, coffee types, and duration of studies, an explanation for the trials’ findings (37-39) regarding no beneficial effect of coffee on HOMA-IR may be the differences in weight of the studied samples.”
BackgroundSalgado, A. L. F. D. A., Carvalho, L. D., Oliveira, A. C., Santos, V. N. D., Vieira, J. G., & Parise, E. R. (2010) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032010000200009 · Cited by 315 · cited 1×
“In the present study, the mean values of HOMA-IR in both groups were greater than those of healthy adults (36).”
ResultCoffee components and cardiovascular risk: beneficial and detrimental effects
Godos, J., Pluchinotta, F. R., Marventano, S., Buscemi, S., Li Volti, G., Galvano, F., & Grosso, G. (2014) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2014.940287 · Cited by 210 · cited 1×
“Bioactive phytochemicals of coffee have drawn attention due to their reported biological properties such as antioxidant and anti-inflammatory activities (19), increased fatty acid oxidation and insulin sensitivity, and modulation of glucose absorption and utilization (20).”
Background
Cited by
Mansour, A., Mohajeri-Tehrani, M. R., Samadi, M., Qorbani, M., Merat, S., Adibi, H., Poustchi, H., & Hekmatdoost, A. (2021) · Nutrition Journal · doi:10.1186/s12937-021-00694-5 · Cited by 98
“Secondary endpoints were improvements in metabolic (including fasting glucose, homeostasis model assessmentestimated insulin resistance (HOMA-IR), hemoglobin A1c (HBA1C), C-peptide, insulin and lipid profiles) and inflammatory (including nuclear factor k-B (NF-KB), tumor necrosis factor (TNF-α), high sensitive- C reac…”
BackgroundInfluentialNutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis
Komolafe, O., Buzzetti, E., Linden, A., Best, L. M., Madden, A. M., Roberts, D., Chase, T. J., Fritche, D., Freeman, S. C., Cooper, N. J., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013157.pub2 · Cited by 21
Linden-Torres, E., Zambrano-Galván, G., Sahebkar, A., Ríos-Mier, M., & Simental-Mendía, L. E. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.07.010 · Cited by 15
Metadata
- Authors
- Shahmohammadi, H. A., Hosseini, S. A., Hajiani, E., Malehi, A. S., & Alipour, M.
- Venue
- Hepatitis Monthly
- Publisher
- Brieflands
- Published
- 2017-03-26
- Volume
- 17
- Issue
- 4
- ISSN
- 1735-143X (ISSN-L)
- 1735-3408
- OpenAlex
- W2602115840
- Cited by
- 61
- References
- 8
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Green Coffee Bean Extract Supplementation on Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.5812/hepatmon.45609
- The paper
- Shahmohammadi, H. A., Hosseini, S. A., Hajiani, E., Malehi, A. S., & Alipour, M. (2017). Effects of Green Coffee Bean Extract Supplementation on Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Hepatitis Monthly. https://doi.org/10.5812/hepatmon.45609
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.